Neurotrigger Ltd. filed a Form D with the Securities and Exchange Commission on 2025-12-30.
Neurotrigger Ltd. filed a Form D notice of an exempt securities offering with the SEC on December 30, 2025. The filing reports $725K sold. Its industry group is Other Health Care. It names Nikolai Kunicher (Chief Executive Officer), Michal Marks (Chief Operating Officer and Director), Prof. Eyal Gur (Medical Director) (SEC Form D, December 30, 2025).
Sell to companies like Neurotrigger Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-12-30 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Neurotrigger Ltd.
Free to see. No signup.
More on the people and the money behind Neurotrigger Ltd., from the filings we hold.
Other Health Care raises filed within 90 days of this one, largest first.
Get an email when Neurotrigger Ltd. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Neurotrigger Ltd. raises, hires or launches. No email unless you switch it on.
Watch Neurotrigger Ltd. →Get the full cited report on Neurotrigger Ltd.
What the filing shows about Neurotrigger Ltd.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Neurotrigger Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 864 filings in Other Health Care, totalled by week. The dot is this raise, $725K, on the same scale — one filing against the whole group's total, so it sits low by construction.
On the filing as: Executive Officer.
Nikolai Kunicher is named as Chief Executive Officer on the Form D that Neurotrigger Ltd. filed with the SEC on 30 December 2025, one of 9 people that filing names.
On the filing as: Executive Officer, Director.
Michal Marks is named as Chief Operating Officer and Director on the Form D that Neurotrigger Ltd. filed with the SEC on 30 December 2025, one of 9 people that filing names.
On the filing as: Executive Officer.
Prof. Eyal Gur is named as Medical Director on the Form D that Neurotrigger Ltd. filed with the SEC on 30 December 2025, one of 9 people that filing names.
On the filing as: Executive Officer, Director.
Dr. Assaf Deutsch is named as R&D Director and Director on the Form D that Neurotrigger Ltd. filed with the SEC on 30 December 2025, one of 9 people that filing names.
Shachar Paz is named as Director on the Form D that Neurotrigger Ltd. filed with the SEC on 30 December 2025, one of 9 people that filing names.
Dr. Hagit Deutsch is named as Director on the Form D that Neurotrigger Ltd. filed with the SEC on 30 December 2025, one of 9 people that filing names.
Shalom Auerbach is named as Director on the Form D that Neurotrigger Ltd. filed with the SEC on 30 December 2025, one of 9 people that filing names.
James Mazzo is named as Director on the Form D that Neurotrigger Ltd. filed with the SEC on 30 December 2025, one of 9 people that filing names.
Dr. Barak Azmon is named as Director on the Form D that Neurotrigger Ltd. filed with the SEC on 30 December 2025, one of 9 people that filing names.
9 people named on the filing — 4 holding an executive role and 5 as directors only.
Named as of the 2025-12-30 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Neurotrigger Ltd.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Neurotrigger Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Neurotrigger Ltd. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Neurotrigger Ltd.You get an alert in MentionFox the next time this company shows up.
If you're behind Neurotrigger Ltd.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Neurotrigger Ltd.. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/neurotrigger-ltd-form-d-25000001